drugset / Trial / NCT00154687

Weekly TP-HDFL in the Treatment of Advanced TCC

NCT00154687 ↗

Phase 2 Completed 40 enrolled National Taiwan University Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of Weekly TP-HDFL in advanced transitional cell carcinoma in terms of response rate and overall survival.

Timeline

Start
2000-10
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Paclitaxel Small molecule — —
Subject fluorouracil Small molecule — —